Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference45 articles.
1. Cardiovascular actions of incretin-based therapies;JR Ussher;Circ Res,2014
2. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition;J Zhong;Circ Res,2015
3. Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types;X Ou;Blood,2013
4. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors;EE Mulvihill;Endocrine reviews,2014
5. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;DJ Drucker;Lancet,2006
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Simple Liquid Chromtographic Method for the Simultaneous Estimation of Antidiabetic Drugs in Spiked Human Plasma: Heteroscedasticity Study;Research Journal of Pharmacy and Technology;2024-07-24
2. Potential Clinical Implications of Senotherapies for Cardiovascular Disease;Circulation Journal;2023-10-26
3. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases;Cells;2023-05-02
4. Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-08-10
5. Cardiac Cx43 Signaling Is Enhanced and TGF-β1/SMAD2/3 Suppressed in Response to Cold Acclimation and Modulated by Thyroid Status in Hairless SHRM;Biomedicines;2022-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3